Gene: EPN3
Official Full Name: epsin 3provided by HGNC
Gene Summary: Predicted to enable clathrin binding activity and phospholipid binding activity. Predicted to be involved in endocytosis. Located in several cellular components, including clathrin-coated vesicle; cytoplasmic side of plasma membrane; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17943 | EPN3 Knockout cell line (HCT 116) | Human | EPN3 | 1:2~1:4 | Negative | Online Inquiry |
EPN3 Gene Knockout Cell Lines are specialized cellular models that have undergone precise genome editing to inactivate the EPN3 gene. This product enables researchers to elucidate the gene's functions and its role in various biological processes. By utilizing CRISPR/Cas9 or similar gene-editing technologies, EPN3 knockout cell lines provide a robust platform for functional assays and pathway analyses.
The primary mechanism of action behind EPN3 knockout cell lines lies in their ability to eliminate the expression of the EPN3 protein, which is implicated in critical cellular processes such as endocytosis, autophagy, and signal transduction. By studying these cells, researchers can investigate the consequences of EPN3 depletion on cellular behaviors, providing valuable insights into disease mechanisms and potential therapeutic targets.
In research and clinical settings, EPN3 knockout cell lines hold significant scientific importance. They serve as essential tools in pharmacological studies, allowing scholars to screen potential drug candidates or assess the efficacy of therapeutic interventions aimed at diseases where EPN3 plays a pivotal role. Furthermore, these cell lines can facilitate innovative research in cancer biology, metabolic disorders, and neurodegenerative diseases.
What sets EPN3 Gene Knockout Cell Lines apart from alternative models is their high specificity and reliable performance in diverse experimental applications. Our products undergo extensive validation, ensuring that they have regained optimal functionality post-knockout, which eliminates false results and enhances reproducibility in experiments. This unique feature makes them an invaluable asset for researchers seeking to derive actionable insights from their studies.
Given the intricate nature of modern biological research, investing in EPN3 Gene Knockout Cell Lines can significantly advance understanding in numerous fields. They offer not only a clear pathway to study gene function but also enhance the overall quality and credibility of research outcomes, making them essential for both basic research and translational applications.
Our company prides itself on its expertise in developing high-quality biological products, ensuring that scientists and clinicians have access to reliable tools that drive innovation and discovery. With a firm commitment to advancing scientific knowledge, we stand at the forefront of providing superior genetic models that meet the complex demands of today's research landscape.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.